2919 |
Novel Therapy in CLI as Stem Cells, Growth Factors, Are They Clinically Beneficial or Horizon Therapy? |
Krishna Rocha-Singh |
Apr. 21. 16 |
2918 |
Use of AVP II in Large and Long Ducts During Infancy |
Bharat Dalvi |
Apr. 21. 16 |
2917 |
What Is the Best Angiographic Endpoint for Revascularization?(Angiosome or "Straight-Line" Flow) |
Osamu Iida |
Apr. 21. 16 |
2916 |
Current and Upcoming Evidence-Based Approach in CLI: Endovascular vs. Surgery (OLIVE 3-Year and BEST-CLI Trial) |
Mark W. Burket |
Apr. 21. 16 |
2915 |
Balloon Valvuloplasty for Critical Aortic Stenosis |
Neil Wilson |
Apr. 21. 16 |
2914 |
CLI: Best Medical Therapy - Statin, Antiplatelet, Smoking and Guidelines-Based Management |
John Robert Laird, Jr. |
Apr. 21. 16 |
2913 |
PDA Stenting in Babies |
Worakan Promphan |
Apr. 21. 16 |
2912 |
DCB or DES in SFA treatment: A Difficult Choice? |
Herman Schroë |
Apr. 21. 16 |
2911 |
Not Alone, Combination Might Be Better, Which One Could Be Better?: Atherectomy with DCB |
Ravish Sachar |
Apr. 21. 16 |
2910 |
Novel Stent Technology Can Shed Light: SUPERA or BVS |
Richard R. Heuser |
Apr. 21. 16 |